论文信息 - Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial - 字舞流文

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

D. Schadendorf | P. Ascierto | M. Smylie | I. Svane | P. Rutkowski | R. Gonzalez | C. Robert | C. Lebbé | A. Menzies | A. Saci | N. Meyer | L. Mortier | I. Márquez-Rodas | L. Rollin | T. Eigentler | M. Ajaz | J. Pigozzo | E. Grigoryeva | J. Lord-Bessen